SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator beambe, BigBake1, LongRun8, TRUTH
Search This Board:
Last Post: 3/2/2015 8:31:45 AM - Followers: 126 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.



CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.



ADJUVANT PIPELINE:





CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for NVAX
NVAX News: Novavax - Buy The Dip For The Long Term 03/03/2015 03:01:09 AM
NVAX News: Current Report Filing (8-k) 02/27/2015 04:36:42 PM
NVAX News: Novavax's (NVAX) CEO Stanley Erck on Q4 2014 Results - Earnings Call Transcript 02/26/2015 11:00:59 PM
NVAX News: Novavax Reports Fourth Quarter and Year-End 2014 Financial Results 02/26/2015 04:37:31 PM
NVAX News: Novavax Reports Fourth Quarter and Year-End 2014 Financial Results 02/26/2015 04:18:35 PM
News News Alert: Novavax - Buy The Dip For The Long Term 03/03/2015 03:01:09 AM
PostSubject
#2119  Sticky Note **Novavax CEO: Vaccination Value / Mad Money / CNBC** TRUTH 02/19/15 09:05:49 AM
#2136   Share Price of Novavax, Inc. Drops by -3.79% TRUTH 03/02/15 08:31:44 AM
#2135   More R&D definitely translates to more costs, less TRUTH 03/01/15 09:11:55 AM
#2134   J.P. Morgan Reiterates Upbeat View Of Novavax Following underdog150 03/01/15 08:12:27 AM
#2133   Exactly, and if NVAX wanted to be profitable owen3838 02/27/15 10:41:11 AM
#2132   More R&D definitely translates to more costs, less tttengy 02/27/15 10:27:27 AM
#2131   Smart move is buying on todays dip. More owen3838 02/27/15 09:09:40 AM
#2130   Noooo, doesnt seem like it! tttengy 02/26/15 07:56:32 PM
#2129   Novavax Losses Widen On Expenses TRUTH 02/26/15 05:49:34 PM
#2128   **Today's Conference Call Details Are As Follows:** TRUTH 02/26/15 08:27:28 AM
#2127   The March to $10 by March 01...?? TRUTH 02/25/15 09:23:07 AM
#2126   The March to $10 by March 01...?? TRUTH 02/20/15 04:20:08 PM
#2125   Just closed my Feb 20 $8 call position... SJOGRINGO 02/20/15 01:35:20 PM
#2124   Healthcare Stocks In Review-Novavax (NVAX), TRUTH 02/20/15 07:57:39 AM
#2123   The March to $10 by March 01...?? SJOGRINGO 02/19/15 11:36:45 PM
#2122   Stability in the 9's.... TRUTH 02/19/15 02:37:35 PM
#2121   Understanding CRE, the 'nightmare' superbug that killed 2 TRUTH 02/19/15 11:54:53 AM
#2120   Novavax, Inc. Analyst Rating Update TRUTH 02/19/15 09:12:17 AM
#2119   **Novavax CEO: Vaccination Value / Mad Money / CNBC** TRUTH 02/19/15 09:05:49 AM
#2118   Speculation on Novavax share price in next 3 months? owen3838 02/17/15 07:38:22 PM
#2117   I'm glad to see this continuing to slowly sarshee 02/17/15 01:10:38 PM
#2116   Nvv.f on Yahoo Finance- Frankfurt trading in Euros.. (1=$1.12) SJOGRINGO 02/16/15 06:59:02 PM
#2115   I do too. I have several of these sarshee 02/16/15 10:14:02 AM
#2114   Novavax CEO: Vaccination Value / Mad Money / CNBC TRUTH 02/15/15 10:01:04 AM
#2113   Hoping this marks the beginning of even greater TRUTH 02/14/15 07:38:01 AM
#2112   Exactly. They have a lot going for them. LongRun8 02/13/15 07:27:13 PM
#2111   PLUS can be transported and stored under "normal" SJOGRINGO 02/13/15 06:58:34 PM
#2110   Good interview. Focused mainly on Ebola, but LongRun8 02/13/15 06:51:33 PM
#2109   NVAX CEO interviewed on Cramer CNBC tonight.. SJOGRINGO 02/13/15 06:44:32 PM
#2108   Certainly is sustaining these levels well, Sced 13 BigBake1 02/12/15 05:59:42 PM
#2107   "Novavax have risen more than 60 percent since SJOGRINGO 02/12/15 03:58:06 PM
#2106   CNBC made short mention of NVAX and Ebola SJOGRINGO 02/12/15 03:39:40 PM
#2105   Definitely great news. The run up in LongRun8 02/12/15 01:51:31 PM
#2104   Great News about the Phase I trials of sarshee 02/12/15 12:49:33 PM
#2103   Stability in the 8's.... TRUTH 02/11/15 04:54:17 PM
#2102   Sounds good to me. sarshee 02/10/15 11:24:09 AM
#2101   institutions. Buying shares. TOM611 02/10/15 11:18:35 AM
#2100   I'm glad to see the upwards movement, I sarshee 02/10/15 11:14:33 AM
#2099   8.37 new hod & hoy , TOM611 02/07/15 12:00:56 PM
#2098   The MM want it to die stockwinner 02/06/15 10:27:16 PM
#2097   why did run die @ $8.30? SJOGRINGO 02/06/15 09:32:27 PM
#2096   Blackrock purchase 16 million shares. jcoukr 01/30/15 08:17:02 AM
#2095   There has been a new suspected case of Princes 01/29/15 07:39:41 PM
#2094   NVAX $8 in pre-market, albeit small volume, but LongRun8 01/28/15 08:46:50 AM
#2093   Etablished NEW position Today... SJOGRINGO 01/26/15 03:36:19 PM
#2092   Short here near days high, 7.65. Looking for djsleepy860 01/21/15 11:27:16 AM
#2091   * * $NVAX Video Chart 01-20-15 * * ClayTrader 01/20/15 04:55:29 PM
#2090   NVAX very nice volume and price action past LongRun8 01/20/15 02:10:13 PM
#2089   Wow 21 000 000 at the bell! HandyMan2000 01/16/15 04:18:09 PM
#2088   I have a feeling that breakage through the HandyMan2000 01/16/15 01:45:53 PM
#2087   imo if the 29 000 000 shorts get squeezed HandyMan2000 01/16/15 01:29:22 PM
PostSubject